medroxyprogesterone has been researched along with Peritoneal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauernhofer, T; Gürtl-Lackner, B; Höfler, G; Ranner, G; Reisinger, E; Samonigg, H; Schmid, M; Smola, M; Stöger, H | 1 |
| Deligdisch, L; Goodman, HM; Kredentser, D | 1 |
| Haney, AF; Weinberg, JB | 1 |
1 review(s) available for medroxyprogesterone and Peritoneal Neoplasms
| Article | Year |
|---|---|
Sequential treatment of recurrent mesenteric desmoid tumor.
Topics: Adenomatous Polyposis Coli; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fibromatosis, Aggressive; Goserelin; Humans; Interferon-gamma; Medroxyprogesterone; Mesentery; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Peritoneal Neoplasms; Tamoxifen; Tomography, X-Ray Computed | 1996 |
2 other study(ies) available for medroxyprogesterone and Peritoneal Neoplasms
| Article | Year |
|---|---|
Postmenopausal endometriosis associated with hormone replacement therapy. A case report.
Topics: Endometriosis; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Peritoneal Neoplasms | 1989 |
Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate.
Topics: Adult; Ascitic Fluid; Endometriosis; Female; Humans; Leukocyte Count; Medroxyprogesterone; Menstrual Cycle; Menstruation Disturbances; Peritoneal Neoplasms; Peritonitis | 1988 |